Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors (vol 14, pg 3109, 2004)

被引：0

作者：

Jeong, Tae-Sook ^{[1
]}

Kim, Kyung Soon ^{[1
]}

An, Sojin ^{[1
]}

Cho, Kyung-Hyun ^{[1
]}

Lee, Sangku ^{[1
]}

Lee, Woo Song ^{[1
]}

机构：

[1] Korea Res Inst Biosci & Biotechnol, Natl Res Lab Lipid Metab & Atherosclerosis, Taejon 305333, South Korea

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 08期

关键词：

D O I：

10.1016/j.bmcl.2004.03.113

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：2364 / 2364

页数：1

共 47 条

[21] NOVEL ACYL-COA-CHOLESTEROL ACYLTRANSFERASE INHIBITORS - SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 3-QUINOLYLUREA DERIVATIVES
TAWADA, H
HARCOURT, M
KAWAMURA, N
KAJINO, M
ISHIKAWA, E
SUGIYAMA, Y
IKEDA, H
MEGURO, K
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (13) : 2079 - 2084
[22] Tetrazole-substituted ureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT). A novel preparation of ureas from weakly nucleophilic amines
Purchase, CF
White, AD
Anderson, MK
Bocan, TMA
Bousley, RF
Hamelehle, KL
Homan, R
Krause, BR
Lee, P
Mueller, SB
Speyer, C
Stanfield, RL
Reindel, JF
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (15) : 1753 - 1758
[23] 3-Heptylamino-5-phenylpyridazine derivatives as analogues of acyl-CoA:: Cholesterol acyltransferase inhibitors containing the N-heptyl-N′-arylureidic moiety
Gelain, Arianna
Barlocco, Daniela
Kwon, Byong-Mog
Jeong, Tae-Sook
Im, Kyung-Ran
Legnani, Laura
Toma, Lucio
ARCHIV DER PHARMAZIE, 2006, 339 (12) : 645 - 651
[24] Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents:: Synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates
Lee, HT
Roark, WH
Picard, JA
Sliskovic, DR
Roth, BD
Stanfield, RL
Hamelehle, KL
Bousley, RF
Krause, BR
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (03) : 289 - 294
[25] Structure-activity relationships of N-(3,5-dimethoxy-4-n-octyloxycinnamoyl)-N′-(3,4-dimethylphenyl)piperazine and analogues as inhibitors of acyl-CoA:: Cholesterol O-acyltransferase
Ohishi, K
Aiyama, R
Hatano, H
Yoshida, Y
Wada, Y
Yokoi, W
Sawada, H
Watanabe, T
Yokokura, T
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (07) : 830 - 839
[26] A novel endoplasmic reticulum-derived organelle abundantly present in cholesterol-rich human macrophages and expresses elevated acyl-coA:cholesterol acyltransferase 1 enzyme activity
Sakashita, Naomi
Chang, Catherine C.
Lei, Xaofeng
Takeya, Motohiro
Chang, Ta-Yuan
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E86 - E86
[27] Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA: cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 3
Ohtawa, Masaki
Yamazaki, Hiroyuki
Ohte, Satoshi
Matsuda, Daisuke
Ohshiro, Taichi
Rudel, Lawrence L.
Omura, Satoshi
Tomoda, Hiroshi
Nagamitsu, Tohru
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (13) : 3798 - 3801
[28] Human acyl-CoA: Cholesterol acyltransferase-1 is a homotetrameric enzyme in intact cells and in vitro. Vol. 274 (1999) 36139-36145
Yu, Chunjiang
Chen, Jun
Lin, Song
Liu, Jay
Chang, Catherine C.Y.
Chang, Ta-Yuan
Journal of Biological Chemistry, 2000, 275 (08)
[29] Design, synthesis and structure-activity relationship studies of novel 4,4-bis(trifluoromethyl)imidazolines as acyl-CoA: Cholesterol acyltransferase (ACAT) inhibitors and antihypercholesterolemic agents
Li, HY
DeLucca, I
Boswell, GA
Billheimer, JT
Drummond, S
Gillies, PJ
Robinson, C
BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (07) : 1345 - 1361
[30] Inhibitors of acyl-CoA:cholesterol O-acyltransferase.: 3.: Discovery of a novel series of N-alkyl-N-[(fluorophenoxy)benzyl]-N′-arylureas with weak toxicological effects of adrenal glands
Tanaka, A
Terasawa, T
Hagihara, H
Ishibe, N
Sawada, M
Sakuma, Y
Hashimoto, M
Takasugi, H
Tanaka, H
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (22) : 4408 - 4420

← 1 2 3 4 5 →